Literature DB >> 34337550

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.

Diviya Gupta1, Shumei Kato2, Razelle Kurzrock2.   

Abstract

Entities:  

Keywords:  COVID-19; NCI-designated comprehensive cancer center; cancer clinical trials; telemedicine; trial enrollment

Year:  2020        PMID： 34337550      PMCID： PMC8320380          DOI： 10.36401/jipo-20-30

Source DB:  PubMed          Journal:  J Immunother Precis Oncol        ISSN： 2590-017X


× No keyword cloud information.
  5 in total

1.  Rethinking cancer clinical trials for COVID-19 and beyond.

Authors:  Mehmet Goksu; Bruno H R de Paula; Gary J Doherty
Journal:  Nat Cancer       Date:  2020-06

2.  Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.

Authors:  David M Waterhouse; R Donald Harvey; Patricia Hurley; Laura A Levit; Edward S Kim; Heidi D Klepin; Kathryn Finch Mileham; Grzegorz Nowakowski; Caroline Schenkel; Courtney Davis; Suanna S Bruinooge; Richard L Schilsky
Journal:  JCO Oncol Pract       Date:  2020-05-12

3.  Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

Authors:  Edward S Kim; Suanna S Bruinooge; Samantha Roberts; Gwynn Ison; Nancy U Lin; Lia Gore; Thomas S Uldrick; Stuart M Lichtman; Nancy Roach; Julia A Beaver; Rajeshwari Sridhara; Paul J Hesketh; Andrea M Denicoff; Elizabeth Garrett-Mayer; Eric Rubin; Pratik Multani; Tatiana M Prowell; Caroline Schenkel; Marina Kozak; Jeff Allen; Ellen Sigal; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2017-10-02       Impact factor: 44.544

4.  Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.

Authors:  Joseph M Unger; Charles D Blanke; Michael LeBlanc; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2020-06-01

5.  COVID-19 exacerbating inequalities in the US.

Authors:  Aaron van Dorn; Rebecca E Cooney; Miriam L Sabin
Journal:  Lancet       Date:  2020-04-18       Impact factor: 79.321
  5 in total
  4 in total

1.  The immune system, cancer, and pathogens: It takes three to tango!

Authors:  Joud Hajjar
Journal:  J Immunother Precis Oncol       Date:  2021-05-14

2.  COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining.

Authors:  Aakash Desai; Vivek Subbiah
Journal:  J Immunother Precis Oncol       Date:  2020-11-16

3.  The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research.

Authors:  Lada Leyens; Tracy Simkins; Nafsika Kronidou Horst
Journal:  Trials       Date:  2022-09-30       Impact factor: 2.728

4.  Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.

Authors:  Sheila A Prindiville; Gisele A Sarosy; David Loose; Henry Ciolino; James H Doroshow
Journal:  Cancer J       Date:  2022 Mar-Apr 01       Impact factor: 2.074
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.